Synthesis and Bioinformatics Study of 2-Nitrocinnamaldehyde Derivatives as an Anti MCF-7 Breast Cancer Cells

Conventional and systemic treatments of breast cancer are commonly found to expose unexpected side effects. Thus, a new drug design is intensively explored to anticipate the related risks. This work aimed to synthesize and characterize the chalcone derivatives based on a cinnamaldehyde skeleton (9 - 12). Further biological assay of the derivatives against MCF-7 breast cancer cell lines and their molecular docking analysis was also performed to obtain a more potential chemical structure for the active compounds. Four compounds of a 2-Nitrocinnamaldehyde-based scaffold, 1-(4-aminophenyl)-5-(2-nitrophenyl)-penta-2,4-dien-1-one (9), 1-(4-bromophenyl)-5-(2-nitrophenyl)-penta-2,4-dien-1-one (10), 5-(2-nitrophenyl)-1-(p-tolyl)-penta-2,4-dien-1-one (11), and 5-(2-nitrophenyl)-1-(pyridine-3-yl)-penta-2,4-dien-1-one (12) were successfully synthesized with a chemical yield of 29 - 99 %. The synthetic method employed a one-pot Claisen-Schmidt coupling reaction using a NaOH/KOH base catalyst, while their characterization was based on spectroscopic data and literature comparison. An in-vitro MTT bioassay against MCF-7 cancer cells revealed the IC50 values of the derivatives of 9, 10, 11, and 12 were 178, 376, >500, and 118.20 μg/mL, respectively. Molecular docking showed that the most potent compound in this series (12) had the lowest binding energy (–8.56 kcal/mol) and created an essential H-bond with hinge region residue, Met793. Docking-based structural optimization of 12 showed that incorporating 3 important pharmacophores commonly found in EGFR kinase inhibitors, fused heterocyclic, hydrophobic group, and propylmorpholine moiety, resulted in lower binding energy (–9.41 kcal/mol). Perhaps the modified 12 could exhibit a more potent toxicity against MCF-7. HIGHLIGHTS Anti-MCF-7 breast cancer potential of new cinnamaldehyde derivatives. A one-pot Claisen-Schmidt coupling reaction of new chalcone derivatives. A bioinformatics study of a more potent structure modification. GRAPHICAL ABSTRACT

Authors

Institutions

Publication Details

Journal
Trends in Sciences
Published
2025-03-20
DOI
https://doi.org/10.48048/tis.2025.9586
Primary Topic
Synthesis and biological activity
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Synthesis and Bioinformatics Study of 2-Nitrocinnamaldehyde Derivatives as an Anti MCF-7 Breast Cancer Cells

Juliandri Juliandri, Indra Lasmana Tarigan, Jamaludin Al Anshori, Madyawati Latief et al.
Trends in Sciences
Synthesis and biological activity
article

Synthesis and Bioinformatics Study of 2-Nitrocinnamaldehyde Derivatives as an Anti MCF-7 Breast Cancer Cells

Juliandri Juliandri, Indra Lasmana Tarigan, Jamaludin Al Anshori, Madyawati Latief, Muhammad Naufal, Alidya Fitri Kusuma Wardani
article en

Abstract

Conventional and systemic treatments of breast cancer are commonly found to expose unexpected side effects. Thus, a new drug design is intensively explored to anticipate the related risks. This work aimed to synthesize and characterize the chalcone derivatives based on a cinnamaldehyde skeleton (9 - 12). Further biological assay of the derivatives against MCF-7 breast cancer cell lines and their molecular docking analysis was also performed to obtain a more potential chemical structure for the active compounds. Four compounds of a 2-Nitrocinnamaldehyde-based scaffold, 1-(4-aminophenyl)-5-(2-nitrophenyl)-penta-2,4-dien-1-one (9), 1-(4-bromophenyl)-5-(2-nitrophenyl)-penta-2,4-dien-1-one (10), 5-(2-nitrophenyl)-1-(p-tolyl)-penta-2,4-dien-1-one (11), and 5-(2-nitrophenyl)-1-(pyridine-3-yl)-penta-2,4-dien-1-one (12) were successfully synthesized with a chemical yield of 29 - 99 %. The synthetic method employed a one-pot Claisen-Schmidt coupling reaction using a NaOH/KOH base catalyst, while their characterization was based on spectroscopic data and literature comparison. An in-vitro MTT bioassay against MCF-7 cancer cells revealed the IC50 values of the derivatives of 9, 10, 11, and 12 were 178, 376, >500, and 118.20 μg/mL, respectively. Molecular docking showed that the most potent compound in this series (12) had the lowest binding energy (–8.56 kcal/mol) and created an essential H-bond with hinge region residue, Met793. Docking-based structural optimization of 12 showed that incorporating 3 important pharmacophores commonly found in EGFR kinase inhibitors, fused heterocyclic, hydrophobic group, and propylmorpholine moiety, resulted in lower binding energy (–9.41 kcal/mol). Perhaps the modified 12 could exhibit a more potent toxicity against MCF-7. HIGHLIGHTS Anti-MCF-7 breast cancer potential of new cinnamaldehyde derivatives. A one-pot Claisen-Schmidt coupling reaction of new chalcone derivatives. A bioinformatics study of a more potent structure modification. GRAPHICAL ABSTRACT

Trends in SciencesVol. 22(5)
Universitas Jambi (ID), Padjadjaran University (ID)
Universitas Padjadjaran, Universitas Jambi
Openalex Percentile: Top 94%
Synthesis and biological activity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.